Stocks and Investing Stocks and Investing
Tue, December 3, 2024
[ 01:01 AM ] - United States, Thomas Matters
Jeff Bezos is betting millions on a Nvidia rival
[ 12:31 AM ] - United States, Thomas Matters
An active 'ethical' MF scheme comes to market aft .. ears. Chirag Mehta of Quantum MF explains trigger
[ 12:01 AM ] - United States, Thomas Matters
Top 10 mutual funds to invest in December 2024
[ 12:01 AM ] - United States, Thomas Matters
2 fantastic ASX growth stocks to buy and hold for 10 years
Mon, December 2, 2024
[ 11:31 PM ] - United States, Thomas Matters
What is an IPO?
[ 11:31 PM ] - United States, Thomas Matters
Boeing: Selling $83 Billion Of Inventories Is Essential To A Stronger Buy
[ 11:31 PM ] - United States, Thomas Matters
Hedge funds profit from 'Trump trades' around US election
[ 10:31 PM ] - United States, Thomas Matters
Thesis Gold Upsizes Previously-Announced Private Placement To $10 Million
[ 10:01 PM ] - United States, Thomas Matters
Buying ASX 200 dividend stocks? Here's what to expect in 2025
[ 09:31 PM ] - United States, Thomas Matters
Why Wolfspeed Stock Is Soaring Today
[ 09:31 PM ] - United States, Thomas Matters
1 Historically Cheap Stock-Split Stock to Buy Han .. Artificial Intelligence (AI) Stock Split to Avoid
[ 09:31 PM ] - United States, Thomas Matters
Peter Brandt Hints At Litecoin Price Rally To $420 Mirroring XRP's Path
[ 09:31 PM ] - United States, Thomas Matters
Nvidia Bought 6 Artificial Intelligence (AI) Stocks, but This 1 Has Soared the Most
[ 09:01 PM ] - United States, Thomas Matters
Here's Why Fiserv (FI) is a Strong Growth Stock
[ 09:01 PM ] - United States, Thomas Matters
Warren Buffett Owns 1 Vanguard ETF That Could Be .. to Plunge, According to a Top Wall Street Analyst
[ 09:01 PM ] - United States, Thomas Matters
Muni Bond Funds Are Attractive Now If You Have Large Taxable Assets
[ 08:31 PM ] - United States, Thomas Matters
Stock Market News: Dow Drops, Nasdaq Heads to New Record
[ 07:01 PM ] - United States, Thomas Matters
TBG: A New And Promising Dividend Growth ETF
[ 06:31 PM ] - United States, Thomas Matters
Why Rio Tinto shares are my top ASX mining sector buy
[ 06:01 PM ] - United States, Thomas Matters
Unusually active option classes on open December 2nd
[ 05:31 PM ] - United States, Thomas Matters
Here's Why News Corp. (NWSA) is a Strong Momentum Stock
[ 05:01 PM ] - United States, Thomas Matters
Xplore Appoints Telecom Industry Leader Brent Johnston as CEO
[ 05:01 PM ] - United States, Thomas Matters
Looking for an ASX dividend stock with a yield of over 10%? I'd buy this one
[ 05:01 PM ] - United States, Thomas Matters
Why Is Merck & Co., Inc. (MRK) Among the Stocks Ray Dalio's Bridgewater Is Crazy About?
[ 05:01 PM ] - United States, Thomas Matters
Stock Market Today: Dow slips; Nasdaq on track for record as Intel, Tesla rally
[ 04:31 PM ] - United States, Thomas Matters
Stock Market Today: Stocks Are Positively Mixed to Open December
[ 04:01 PM ] - United States, Thomas Matters
These Stocks Are Moving the Most Today: Super Mic .. la, Stellantis, Upstart, Gap, Norwegian, and More
[ 04:01 PM ] - United States, Thomas Matters
French Assets Under Pressure as Le Pen Backs No-Confidence Vote
[ 04:01 PM ] - United States, Thomas Matters
China Hits Gold: What Mining Investors Need to Know
[ 04:01 PM ] - United States, Thomas Matters
Why Is Genmab A/S (GMAB) Among the Best High Growth Healthcare Stocks to Invest In Now?

Why Is Genmab A/S (GMAB) Among the Best High Growth Healthcare Stocks to Invest In Now?


Published on 2024-12-02 16:01:08 - Thomas Matters, WOPRAI
  Print publication without navigation

  • We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other high growth healthcare stocks.

Genmab A/S (GMAB) is highlighted as one of the best high-growth healthcare stocks to invest in due to several compelling factors. The company specializes in the development of antibody therapies for cancer treatment, which positions it well in the rapidly expanding oncology market. Genmab's lead product, Darzalex, used for treating multiple myeloma, has shown significant market success, contributing to robust revenue growth. Additionally, Genmab has a promising pipeline with multiple late-stage candidates, suggesting potential for future revenue streams. The company's strategic partnerships, particularly with major pharmaceutical companies like Johnson & Johnson, enhance its market reach and development capabilities. Furthermore, Genmab's financial health is strong, with consistent earnings growth, a solid balance sheet, and increasing cash reserves, which supports further research and development as well as potential acquisitions. These elements combined make Genmab an attractive option for investors looking for growth in the healthcare sector.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/why-is-genmab-a-s-gmab-among-the-best-high-growth-healthcare-stocks-to-invest-in-now/ar-AA1v8S6F ]

Contributing Sources